Position in ILMN
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$233,853
-$5,887 QoQ
Shares Held
1,330
-31.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#683
of 932 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $34,841,755 across 11 Diagnostics & Research names. ILMN ranks #11 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
37,709 | $18,905,784 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
8,911 | $4,719,176 | |
| 3 | DHR |
Danaher Corp /De/
|
20,988 | $3,997,794 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
4,300 | $2,263,692 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
958 | $1,223,854 | |
| 6 | NTRA |
Natera, Inc.
|
3,887 | $1,055,126 | |
| 7 | LH |
Labcorp Holdings Inc.
|
2,428 | $679,840 | |
| 8 | DGX |
Quest Diagnostics Inc
|
3,169 | $671,669 |
All Filings in ILMN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $233,853 | 1,330 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $239,740 | 1,945 | Shares | Sole | 2026-05-15 | |
| 2022-12-31 | $274,587 | 1,358 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $302,020 | 1,583 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $273,037 | 1,481 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,542,234 | 7,276 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $712,564 | 1,873 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $738,210 | 1,820 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,023,079 | 2,162 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||